For the Inventor, By the Inventor

Enter inventor name

Menlo Park, CA, United States of America

Andreas G Moraitis

USPTO Granted Patents = 32 (Patent Applications = 11)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 1.2

ph-index = 4

Forward Citations = 82(Granted Patents)

Location History:

Menlo Park, CA (US) (2017 - 2024)
Sunny Isles Beach, FL (US) (2021 - 2024)

Company Filing History:

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorpoarted

Years Active: 2017-2025

Loading Chart...

Loading Chart...

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12336985 - Methods for shrinking pituitary tumors (2025-06-24),

2. 12290551 - Methods for imaging and treatment of somatostatin-receptor positive tumors (2025-05-06),

3. 12263169 - Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators (2025-04-01),

4. 12102642 - Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators (2024-10-01),

5. 12097192 - Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (2024-09-24),

6. 12005055 - Methods for shrinking pituitary tumors (2024-06-11),

7. 11890289 - Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency (2024-02-06),

8. 11793810 - Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators (2023-10-24),

9. 11744837 - Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients (2023-09-05),

10. 11684612 - Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (2023-06-27),

11. 11590113 - Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (2023-02-28),

12. 11524013 - Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators (2022-12-13),

13. 11389432 - Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent (2022-07-19),

14. 11327083 - Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome (2022-05-10),

15. 11268145 - Methods for treating Cushing's syndrome (2022-03-08),

Title: Andreas G Moraitis: Pioneering Inventor from Menlo Park

Introduction: Andreas G Moraitis is a distinguished inventor based in Menlo Park, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Andreas G Moraitis holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Moraitis has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Andreas G Moraitis has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Andreas G Moraitis stands as a visionary inventor whose work continues to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…